Intuitive Surgical (NASDAQ:ISRG) Hits New 12-Month High – What’s Next?

Intuitive Surgical, Inc. (NASDAQ:ISRG) hit a new 52-week high during trading on Thursday . The stock traded as high as $545.00 and last traded at $545.00, with a volume of 2880 shares traded. The stock had previously closed at $541.82.

Wall Street Analyst Weigh In

ISRG has been the subject of several research reports. JPMorgan Chase & Co. upped their price objective on shares of Intuitive Surgical from $495.00 to $575.00 and gave the stock an “overweight” rating in a report on Friday, October 11th. Redburn Atlantic upgraded shares of Intuitive Surgical from a “neutral” rating to a “buy” rating and increased their price target for the stock from $380.00 to $510.00 in a research note on Friday, August 2nd. Wells Fargo & Company increased their price target on shares of Intuitive Surgical from $466.00 to $549.00 and gave the stock an “overweight” rating in a research note on Friday, October 18th. Stifel Nicolaus increased their price target on shares of Intuitive Surgical from $475.00 to $525.00 and gave the stock a “buy” rating in a research note on Friday, October 18th. Finally, Raymond James increased their price target on shares of Intuitive Surgical from $500.00 to $540.00 and gave the stock an “outperform” rating in a research note on Monday, October 14th. One investment analyst has rated the stock with a sell rating, five have issued a hold rating and fourteen have given a buy rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $524.61.

Intuitive Surgical Stock Performance

The business’s fifty day moving average price is $502.44 and its 200-day moving average price is $461.26. The stock has a market cap of $195.05 billion, a PE ratio of 87.11, a P/E/G ratio of 5.30 and a beta of 1.39.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.24 by $0.32. The firm had revenue of $2.04 billion for the quarter, compared to the consensus estimate of $2.01 billion. Intuitive Surgical had a net margin of 28.51% and a return on equity of 13.41%. Analysts forecast that Intuitive Surgical, Inc. will post 5.45 earnings per share for the current fiscal year.

Insider Transactions at Intuitive Surgical

In other news, CEO Gary S. Guthart sold 18,151 shares of the stock in a transaction that occurred on Wednesday, October 30th. The shares were sold at an average price of $511.63, for a total value of $9,286,596.13. Following the transaction, the chief executive officer now owns 24,219 shares in the company, valued at $12,391,166.97. This represents a 42.84 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, EVP Robert Desantis sold 188 shares of the stock in a transaction that occurred on Thursday, August 29th. The stock was sold at an average price of $482.21, for a total transaction of $90,655.48. Following the completion of the transaction, the executive vice president now owns 5,506 shares in the company, valued at $2,655,048.26. This trade represents a 3.30 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 91,178 shares of company stock worth $45,897,071 in the last quarter. Company insiders own 0.90% of the company’s stock.

Institutional Investors Weigh In On Intuitive Surgical

A number of institutional investors and hedge funds have recently added to or reduced their stakes in ISRG. Massachusetts Financial Services Co. MA bought a new stake in Intuitive Surgical during the 3rd quarter worth approximately $558,807,000. International Assets Investment Management LLC raised its position in shares of Intuitive Surgical by 49,383.6% during the third quarter. International Assets Investment Management LLC now owns 1,090,619 shares of the medical equipment provider’s stock valued at $535,788,000 after buying an additional 1,088,415 shares during the last quarter. Capital Research Global Investors bought a new stake in shares of Intuitive Surgical during the first quarter valued at approximately $374,390,000. FMR LLC raised its position in shares of Intuitive Surgical by 8.3% during the third quarter. FMR LLC now owns 10,971,085 shares of the medical equipment provider’s stock valued at $5,389,765,000 after buying an additional 838,793 shares during the last quarter. Finally, Strategic Financial Concepts LLC raised its position in shares of Intuitive Surgical by 40,221.4% during the second quarter. Strategic Financial Concepts LLC now owns 266,121 shares of the medical equipment provider’s stock valued at $1,184,000 after buying an additional 265,461 shares during the last quarter. Institutional investors own 83.64% of the company’s stock.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.